Lipid membranes have recently been
implicated in protein misfolding
and disease etiology, including for α-synuclein and Parkinson’s
disease. However, studying the intersection of protein complex formation,
membrane interactions, and bilayer disruption simultaneously is challenging.
In particular, the efficacies of small molecule inhibitors for toxic
protein aggregation are not well understood. Here, we used native
mass spectrometry in combination with lipid nanodiscs to study α-synuclein–membrane
interactions. α-Synuclein did not interact with zwitterionic
1,2-dimyristoyl-sn-glycero-3-phosphocholine lipids
but interacted strongly with anionic 1,2-dimyristoyl-sn-glycero-3-phospho(1′-rac-glycerol) lipids,
eventually leading to membrane disruption. Unsaturated 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho(1′-rac-glycerol)
(POPG) lipid nanodiscs were also prone to bilayer disruption, releasing
α-synuclein:POPG complexes. Interestingly, the fibril inhibitor,
(−)-epigallocatechin gallate (EGCG), prevented membrane disruption
but did not prevent the incorporation of α-synuclein into nanodisc
complexes. Thus, although EGCG inhibits fibrillization, it does not
inhibit α-synuclein from associating with the membrane.